Introduction
This paper has two objectives. The first objective is to examine the evidence for the thesis that regression of atherosclerosis (a phenomenon demonstrable in experimental animals) occurs in man. The second objective is to relate the evidence to the more general issue of controlling human atherosclerosis.
The notion that atherosclerosis may regress in man has been a topic of controversy for years. The common experience of cardiologists and cardiovascular pathologists is that the clinical manifestations and the lesions of atherosclerosis worsen with time. The evidence that this is not inevitably true is rather restricted, although it continues to accumulate. Owing to the limited information bearing on the regression of human atherosclerosis, it may be instructive to view the question of regression from a larger set of co-ordinates. This may be done by noting what happens to experimentally induced atherosclerosis in other primates before we examine the question of the regression of human atherosclerosis.
Regression of atherosclerosis in non-human primates
It is taken for granted that human atherosclerosis and its behaviour cannot be directly equated with induced atherosclerotic lesions in primate studies. The justification for reviewing primate data in the present context may be stated in the following proposition: just as primate studies of atherosclerosis have been helpful in elucidating and confirming aspects of atherogenesis applicable to man, so favourable modification of experimentally established atherosclerosis in primates other than man may Supported by U.S. Public Health Service Grant HL-14230 and HL-14388 from the National Heart and Lung Institute.
be useful in indicating possibilities of change in the human lesion.
The author and his colleagues have studied the Rhesus monkey in particular. In their first investigation of regression ( Fig. 1 ) forty animals were used in a long-term study (Armstrong, Warner and Connor, 1970 arterial dilatation or ectasia they were examined in absolute terms (Table 2) . The comparison with widely cited human data is shown in Table 3 . There is very little difference between the elevations in lipid classes found in the atherosclerotic Rhesus monkey and the values in two of the studies, and a greater difference in the third human study. The lipid changes after experimental regression are shown in Table 4 . The principal lipid changes are losses from the artery of excess cholesteryl ester and free cholesterol. Triglycerides appear high in coronary arteries because of adventitial contamination (Abdulla, Adams and Baylis, 1969) , and because adventitial fat (chiefly triglycerides) is trapped among medial fibres and perhaps enters the intimal lipid pools as well (Dayton, Hashimoto and Pearce, 1965) . Triglycerides found to the extent noted in this study and in the previously cited human studies (Table 3) should be regarded as functionally extrinsic to lesion formation.
To this point the data indicate that experimental coronary atherosclerosis regresses morphologically. Combined histological study and biochemical evaluation show that depletion of lipid from the (1966) . § Bottcher et al. (1960) . (Armstrong and Megan, 1974) . The fibrous protein analyses have been presented in detail elsewhere (Armstrong and Megan, 1975) . Arterial collagen changes in atherosclerosis and regression are summarized in Figure 5 . After a significant rise in atherosclerosis, there are non-uniform collagen changes in the early phase of regression (up to 200 days), after which there is a levelling-off by the most conservative interpretation or, according to this study, a significant decline in collagen. The interpretation is this: there are fibrogenic lipid moieties within the artery in atherosclerosis that in regression are either depleted or isolated within fibrous capsules these moieties have evoked. Fibroplasia therefore levels off. In the remodelling of the regressed artery, it is plausible that some of the excess collagen may be lysed. Vesselinovitch et al. (1976) have recently presented data that are also compatible with this concept.
Most, perhaps all, studies dealing with regression in non-human primates up to the present are listed in (Taylor et al., 1962) , and gangrene following peripheral atherosclerosis has been reported (Taylor, Manalo-Estrella and Cox, 1963) . Sudden death occurs as a complication of induced coronary atherosclerosis in some primates (Kramsch and Hollander, 1968) , and ventricular tachycardia requiring cardioversion has sometimes occurred. These selected citations of target organ damage should be regarded as exceptional occurrences in animal studies. As a rule, lesions in primates are less advanced than in man, and rather typically the experimentally-induced lesions bear the special features noted in hyperlipidaemic humans (Watanabe, Tanaka and Yanai, 1968; Roberts, Levy and Fredrickson, 1970; Armstrong and Warner, 1971) .
The question may be raised whether the regression of induced atherosclerosis is due to improvement of less severe lesions with persistence of severe lesions. In the primate the answer is clear: all grades of induced lesions studied to date improve (Armstrong et al., 1970; Tucker et al., 1971) . Coronary arteriography has shown significant narrowing in atherosclerotic monkeys; after comparable atherogenic challenge followed by a regression diet of 20 months (Armstrong and Megan, 1974) the coronary arteries did not show occlusive changes (Lauer and Armstrong, unpublished studies). Indeed, it may be said quite categorically that continued growth of induced lesions do not occur in animals when the regimen is changed from an atherogenic hypercholesterolaemic diet to a regression regimen that permits serum lipids to return to normal. Regardless of the degree to which the induced and partially regressible intimal lesion embodies features of the human lesion, however, it is an imperfect replica of human atherosclerosis.
The human atherosclerotic lesion develops during decades of life unlike the experimental lesions that are induced during a period of months, or in the most prolonged experimental investigations during a few years. The factors underlying the occurrence of atherosclerosis in man are often multiple rather than single, unlike the typical study of experimental atherosclerosis induced by marked hypercholesterolaemia. The fibrous proteins of the intimal connective tissue in man may be presumed to be older, more cross-linked, and less vulnerable to remodelling effects. The lipid in clinically significant arterial lesions is principally extracellular except in some instances of human hyperlipidaemias (Armstrong and Warner, 1971 ). Even if a significant portion of this lipid were depleted, the question of whether the rigid obstructing fibrous skeleton of old lesions would be subsequently remoulded to smaller intralumenal dimensions seems imponderable.
Yet the primate lesion shows amazing metabolic responsiveness: some extracellular as well as intracellular lipid is depleted, there is resolution of necrotic lesions, crystalline lipid tends to diminish slowly, and fibroplasia is eventually contained. To what extent do analogous changes occur in man?
Evidence for regression of atherosclerosis in man Data bearing on regression of human atherosclerosis are summarized in Table 6 . The investigations tabulated are representative of the types of evidence that have been adduced for and against regression of atherosclerosis in man. Not all investigators who found a favourable change regarded it as regression. Eilerson and Faber (1960) , for example, are sometimes cited as having found regression, but they interpreted their data as showing arrest of atherosclerosis in comparison with progression in controls. Before 1960, the undesirable settings of war, infection, and cancer or other wasting disease provided the chief sources of evidence that the rate of progression of atherosclerosis could be altered.
During the current period the use of hypolipidaemic agents, and sometimes surgery, has been evaluated together with diet changes and exercise, and has yielded a measure of further evidence that regression sometimes occurs. Ileal by-pass has been followed by changes in coronary arteriograms interpreted as regression in a few patients (Knight et al., 1972) . The famous case of Starzl who under- went portacaval shunt for homozygous Type II hyperlipoproteinaemia showed regression of atherosclerotic lesions but died suddenly from her advanced myocardial disease (Starzl et al., 1973 (Starzl et al., , 1974a . Among non-surgical regimens both negative and positive results are shown. The negative studies listed are of coronary disease. In retrospect, we might fault them for suboptimal risk factor reduction and perhaps too short an interval between angiographic studies but, without question, there is no evidence of regression and there is some for progression. Blankenhorn has studied the femoral arteries of patients who have survived a myocardial infarct by precise angiographic techniques. After a programme of weight loss, prudent diet, and exercise, he has found evidence of regression in one-third of his patients. Basta has evaluated a single patient instructively. He found angina, hyperlipidaemia, and bilateral renovascular hypertension with high renin levels. After prolonged treatment with diet and combined drug therapy, this 49-year-old woman had remarkable clinical improvement, and a ten-fold reduction in plasma renin to normal; follow-up angiographic studies showed apparent regression of lesions in the coronary arteries and unequivocal regression in the renal arteries.
The control of atherosclerosis in man
The phenomenon of regression in primates has been observed to date only with reference to lesions induced with profound hypercholesterolaemia. The most common background found in human lesions that have shown evidence of regression during clinical studies is likewise hyperlipidaemia. The interplay of multiple risk factors so frequently found in human atherosclerosis has not been evaluated in experimental regression. There is no doubt that hypertension, components of tobacco smoke, and diabetes accelerate intimal connective tissue changes and cause a more advanced lesion.
Can such lesions regress? Recent studies of cholesterol kinetics in severe human lesions have shown a turnover time of one to two years in patients with a variety of risk factors (Jagannathan, 1974) .
This information is of great interest because it suggests that lipid depletion may be possible. Until actual depletion of human arterial lipid has been shown in significant lesions, however, this line of evidence for regression is speculative.
The totality of the data in man, which must include our daily experience, is that there is fairly acceptable evidence of regression of atherosclerosis, but that progression seems overwhelmingly to be the rule. It is entirely possible that most current regimens, as prescribed by us and carried out by patients, are insufficient to alter this pattern. Can this pattern be altered? In a sense, this is to ask whether it is possible to accomplish generally and by more acceptable means what has been reported to occur as a result of wartime privations, cancer, and wasting disease.
The issue is in doubt, but one comment is relevant. It is not helpful to group the special problems of myocardial disease caused by atherosclerosis with those of the disease in the vessel wall, and call the sum of the two the coronary problem. Myocardial disease carries its own risks, separate from those posed by the status of the nutrient arteries. Only primary prevention studies may separate the two.
